40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-34.02%
Negative revenue growth while MTDR stands at 5.74%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-49.00%
Negative gross profit growth while MTDR is at 22.55%. Joel Greenblatt would examine cost competitiveness or demand decline.
-134.64%
Negative EBIT growth while MTDR is at 30.36%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-134.64%
Negative operating income growth while MTDR is at 30.36%. Joel Greenblatt would press for urgent turnaround measures.
-438.75%
Negative net income growth while MTDR stands at 26.82%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-446.30%
Negative EPS growth while MTDR is at 26.32%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-442.59%
Negative diluted EPS growth while MTDR is at 26.32%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.79%
Share reduction while MTDR is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.01%
Reduced diluted shares while MTDR is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.79%
Maintaining or increasing dividends while MTDR cut them. John Neff might see a strong edge in shareholder returns.
-52.86%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-498.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-27.74%
Negative 10Y revenue/share CAGR while MTDR stands at 362.09%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-82.67%
Negative 5Y CAGR while MTDR stands at 362.09%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-69.75%
Negative 3Y CAGR while MTDR stands at 362.09%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-49.52%
Negative 10Y OCF/share CAGR while MTDR stands at 174.01%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-79.75%
Negative 5Y OCF/share CAGR while MTDR is at 174.01%. Joel Greenblatt would question the firm’s operational model or cost structure.
144.33%
3Y OCF/share CAGR at 75-90% of MTDR's 174.01%. Bill Ackman would press for improvements in margin or overhead to catch up.
-198.61%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-588.16%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-129.29%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
-11.04%
Negative equity/share CAGR over 10 years while MTDR stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-75.05%
Negative 5Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-73.23%
Negative 3Y equity/share growth while MTDR is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
760.15%
Stable or rising dividend while MTDR is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
-48.39%
Both lowered dividends mid-term. Martin Whitman might suspect broad sector constraints or strategic shifts from dividends.
-0.10%
Both firms reduced dividends recently. Martin Whitman suspects broader macro or industry issues forcing cost and payout cuts.
-32.09%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-3.39%
Negative asset growth while MTDR invests at 2.89%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-10.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-0.36%
We’re deleveraging while MTDR stands at 36.67%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-66.01%
We cut SG&A while MTDR invests at 42.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.